REDWOOD CITY, Calif.--(BUSINESS WIRE)--SentreHEART, Inc., the manufacturer of the LARIAT Suture Delivery Device, today announced that it has received approval for an Investigational Device Exemption ...
The ligation devices market is poised to experience a steady growth trajectory, with an anticipated compound annual growth rate (CAGR) of 6-7% through 2028. This growth can be attributed to several ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback